In a study on 14 patients, Onisto and colleagues [56] report that a high MMP-2/TIMP-2 ratio correlated with lymph node metastases in breast cancer while it predicted a better outcome in another study [25]. This evidence concerns the gene TIMP2 and breast cancer.